Gregory Sargen - Jun 7, 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Mary Grendell, Attorney-in-fact
Stock symbol
TARA
Transactions as of
Jun 7, 2024
Transactions value $
$0
Form type
4
Date filed
6/10/2024, 06:00 PM
Previous filing
Dec 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +10K $0.00 10K Jun 7, 2024 Common Stock 10K $2.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.